• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双等位基因 TPK1 变异婴儿的硫胺素治疗和良好结局。

Thiamine Treatment and Favorable Outcome in an Infant with Biallelic TPK1 Variants.

机构信息

Department of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Department of Pediatrics, Salzburger Landeskliniken and Paracelsus Medical University Salzburg, Salzburg, Austria.

出版信息

Neuropediatrics. 2021 Apr;52(2):123-125. doi: 10.1055/s-0040-1715631. Epub 2020 Oct 21.

DOI:10.1055/s-0040-1715631
PMID:33086386
Abstract

Episodic encephalopathy due to mutations in the thiamine pyrophosphokinase 1 () gene is a rare autosomal recessive metabolic disorder. Patients reported so far have onset in early childhood of acute encephalopathic episodes, which result in a progressive neurologic dysfunction including ataxia, dystonia, and spasticity. Here, we report the case of an infant with deficiency (compound heterozygosity for two previously described pathogenic variants) presenting with two encephalopathic episodes and clinical stabilization under oral thiamine and biotin supplementation. In contrast to other reported cases, our patient showed an almost normal psychomotor development, which might be due to an early diagnosis and subsequent therapy.

摘要

由于硫胺素焦磷酸激酶 1 () 基因突变引起的发作性脑病是一种罕见的常染色体隐性代谢紊乱。迄今为止报道的患者在儿童早期发病,急性脑病发作导致进行性神经功能障碍,包括共济失调、肌张力障碍和痉挛。在这里,我们报告了一例婴儿 缺乏症(两种先前描述的致病性变异的复合杂合性)的病例,该患儿表现为两次脑病发作,并在口服硫胺素和生物素补充治疗下临床稳定。与其他报道的病例不同,我们的患者表现出几乎正常的精神运动发育,这可能是由于早期诊断和随后的治疗。

相似文献

1
Thiamine Treatment and Favorable Outcome in an Infant with Biallelic TPK1 Variants.双等位基因 TPK1 变异婴儿的硫胺素治疗和良好结局。
Neuropediatrics. 2021 Apr;52(2):123-125. doi: 10.1055/s-0040-1715631. Epub 2020 Oct 21.
2
Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder.硫胺素焦磷酸激酶缺乏症:由 TPK1 基因突变引起的一种罕见的、可治疗的神经退行性疾病。
Neuropediatrics. 2021 Apr;52(2):126-132. doi: 10.1055/s-0040-1715628. Epub 2020 Nov 23.
3
Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations.扩展硫胺素焦磷酸激酶缺乏症的临床和分子谱:一种由TPK1突变引起的可治疗的神经系统疾病。
Mol Genet Metab. 2014 Dec;113(4):301-6. doi: 10.1016/j.ymgme.2014.09.010. Epub 2014 Oct 5.
4
Reduced thiamine binding is a novel mechanism for TPK deficiency disorder.硫胺素结合减少是 TPK 缺乏症的一种新机制。
Mol Genet Genomics. 2019 Apr;294(2):409-416. doi: 10.1007/s00438-018-1517-3. Epub 2018 Nov 27.
5
Thiamine phosphokinase deficiency and mutation in TPK1 presenting as biotin responsive basal ganglia disease.硫胺素磷酸激酶缺乏和 TPK1 突变表现为生物素反应性基底节疾病。
Clin Chim Acta. 2019 Dec;499:13-15. doi: 10.1016/j.cca.2019.07.034. Epub 2019 Aug 9.
6
Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease.家族性硫胺素代谢功能障碍综合征 5 例两例受累同胞病例报告:一种罕见但可治疗的神经退行性疾病。
BMC Neurol. 2022 Sep 29;22(1):373. doi: 10.1186/s12883-022-02887-9.
7
Identification of two novel TPK1 gene mutations in a Chinese patient with thiamine pyrophosphokinase deficiency undergoing whole exome sequencing.在一名接受全外显子组测序的硫胺素焦磷酸激酶缺乏症中国患者中鉴定出两个新的TPK1基因突变。
J Pediatr Endocrinol Metab. 2019 Mar 26;32(3):295-300. doi: 10.1515/jpem-2018-0363.
8
Thiamine pyrophosphokinase deficiency: report of two Chinese cases and a literature review.硫胺素焦磷酸激酶缺乏症:两例中国病例报告及文献综述
Front Pediatr. 2023 Aug 9;11:1173787. doi: 10.3389/fped.2023.1173787. eCollection 2023.
9
Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway.伴有丙酮酸氧化途径缺陷的脑病患儿中焦磷酸硫胺素激酶缺乏。
Am J Hum Genet. 2011 Dec 9;89(6):806-12. doi: 10.1016/j.ajhg.2011.11.007.
10
[Clinical characteristics and genetic analysis of a Chinese pedigree affected with thiamine pyrophosphokinase deficiency].[一个硫胺素焦磷酸激酶缺乏症中国家系的临床特征及基因分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021 Feb 10;38(2):141-144. doi: 10.3760/cma.j.cn511374-20191208-00627.

引用本文的文献

1
The wide phenotypic spectrum of thiamine metabolism dysfunction syndrome 5 and its treatment.硫胺素代谢功能障碍综合征5的广泛表型谱及其治疗。
Orphanet J Rare Dis. 2025 Apr 4;20(1):160. doi: 10.1186/s13023-025-03665-9.
2
Report of a novel recurrent homozygous variant c.620A>T in three unrelated families with thiamine metabolism dysfunction syndrome 5 and review of literature.报告一个新型常染色体纯合变异 c.620A>T 在三个无关的家族性硫胺素代谢功能障碍综合征 5 患者中的发生,同时进行文献复习。
Clin Dysmorphol. 2024 Oct 1;33(4):160-166. doi: 10.1097/MCD.0000000000000490. Epub 2024 Jul 16.
3
Identification of novel mutations in and genes in families exhibiting thiamine metabolism dysfunction syndrome.
在表现出硫胺素代谢功能障碍综合征的家族中鉴定和基因的新突变。
Heliyon. 2024 Mar 6;10(6):e27434. doi: 10.1016/j.heliyon.2024.e27434. eCollection 2024 Mar 30.
4
Thiamine pyrophosphokinase deficiency: report of two Chinese cases and a literature review.硫胺素焦磷酸激酶缺乏症:两例中国病例报告及文献综述
Front Pediatr. 2023 Aug 9;11:1173787. doi: 10.3389/fped.2023.1173787. eCollection 2023.
5
Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease.家族性硫胺素代谢功能障碍综合征 5 例两例受累同胞病例报告:一种罕见但可治疗的神经退行性疾病。
BMC Neurol. 2022 Sep 29;22(1):373. doi: 10.1186/s12883-022-02887-9.
6
Pediatric thiamine deficiency disorders in high-income countries between 2000 and 2020: a clinical reappraisal.2000 年至 2020 年高收入国家小儿硫胺素缺乏症:临床再评估。
Ann N Y Acad Sci. 2021 Aug;1498(1):57-76. doi: 10.1111/nyas.14669. Epub 2021 Jul 26.